Is a complete EYPT research report available?

No complete published report is available for EyePoint, Inc. (EYPT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EyePoint, Inc. (EYPT)

NASDAQ: EYPT · USD

$0.38

+0.02 (+5.0%)· Recorded snapshot

Market cap	32.9M
Revenue (ttm)	2.8M
Net income (ttm)	-306.6M
EPS (ttm)	-$3.76
Shares out	86.2M
Volume	6,102,822
Beta	1.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.8M
Net income (ttm): -306.6M
EPS (ttm): -$3.76
Market cap: 32.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001314102
Company name	EyePoint, Inc.
Country	United States
Country code	US
CUSIP number	30233G209
Earnings date	2026-11-09
Earnings time	bmo
Employees	214
Employees change	49
Employees growth	29.7%
Enterprise value	$-125.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2005-01-27
Is primary listing	Yes
Is SPAC	No
ISIN number	US30233G2093
Last 10-K release date	2026-03-05
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2020-12-09
Last stock split type	Reverse
Market cap	$32.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.38
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	EYPT
U.S. state	Massachusetts
Website	https://eyepoint.bio

Metric

Value

Amount currency

USD

CIK code

0001314102

Company name

EyePoint, Inc.

Country

United States

Country code

CUSIP number

30233G209

Earnings date

2026-11-09

Earnings time

bmo

Employees

214

Employees change

Employees growth

29.7%

Enterprise value

$-125.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1987

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2005-01-27

Is primary listing

Yes

Is SPAC

ISIN number

US30233G2093

Last 10-K release date

2026-03-05

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2020-12-09

Last stock split type

Reverse

Market cap

$32.9M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.38

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-10-28

Symbol

EYPT

U.S. state

Massachusetts

Website

https://eyepoint.bio

Metric	Value
Earnings yield	-987.46%
FCF / EV yield	216.43%
FCF yield	-828.06%
Forward P/S	34.22x
P/B ratio	0.19x
P/S ratio	11.75x
Price / tangible book value	0.2x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-987.46%

FCF / EV yield

216.43%

FCF yield

-828.06%

Forward P/S

34.22x

P/B ratio

0.19x

P/S ratio

11.75x

Price / tangible book value

0.2x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-11,369.3%
Pretax margin	-10,993.79%
Profit per employee	$-1.4M
Revenue per employee	$13,028
ROA	-74.85%
ROA (5Y)	-24.33%
ROCE	-170.19%
ROE	-148.7%
ROE (5Y)	-57.01%
ROIC	-86.42%
SBC / revenue	1,263.02%
Tax / revenue	4.88%

Metric

Value

Operating margin

-11,369.3%

Pretax margin

-10,993.79%

Profit per employee

$-1.4M

Revenue per employee

$13,028

ROA

-74.85%

ROA (5Y)

-24.33%

ROCE

-170.19%

ROE

-148.7%

ROE (5Y)

-57.01%

ROIC

-86.42%

SBC / revenue

1,263.02%

Tax / revenue

4.88%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-94.63%
Revenue growth (Q)	-90.49%
Revenue growth (QoQ)	-27.16%
Revenue growth 10Y	5.58%
Revenue growth 3Y	-57.89%
Revenue growth 5Y	-41.05%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth

-94.63%

Revenue growth (Q)

-90.49%

Revenue growth (QoQ)

-27.16%

Revenue growth 10Y

5.58%

Revenue growth 3Y

-57.89%

Revenue growth 5Y

-41.05%

Revenue growth years

Metric	Value
Capital expenditures	$-4M
Depreciation and amortization	$2.6M
EBIT	$-317M
EBITDA	$-314.4M
EPS	$-3.76
FCF per share	$-3.15
Financing cash flow	$191.7M
Free cash flow	$-271.3M
Free cash flow minus SBC	$-306.5M
Gross profit	$-257.5M
Income taxes	$136,000
Investing cash flow	$114.9M
Net borrowing	$-111,000
Net cash flow	$39.3M
Net income	$-306.6M
Operating cash flow minus SBC	$-302.5M
Operating income	$-317M
Revenue	$2.8M
Stock-based compensation	$35.2M

Metric

Value

Capital expenditures

$-4M

Depreciation and amortization

$2.6M

EBIT

$-317M

EBITDA

$-314.4M

EPS

$-3.76

FCF per share

$-3.15

Financing cash flow

$191.7M

Free cash flow

$-271.3M

Free cash flow minus SBC

$-306.5M

Gross profit

$-257.5M

Income taxes

$136,000

Investing cash flow

$114.9M

Net borrowing

$-111,000

Net cash flow

$39.3M

Net income

$-306.6M

Operating cash flow minus SBC

$-302.5M

Operating income

$-317M

Revenue

$2.8M

Stock-based compensation

$35.2M

Metric	Value
Altman Z-Score	-1.28
Book value per share	$1.96
Debt / equity	0.13
Interest coverage	-9,605.33
Long-term assets	$39.4M
Long-term liabilities	$19.8M
Net cash (debt)	$158.1M
Net cash / market cap	482.61%
Net cash growth	-31.86%
Net debt / equity	-0.95
Piotroski F-Score	1
Property, plant and equipment	$29.9M
Shareholders' equity	$166.4M
Tangible book value	$166.4M
Tangible book value per share	$1.96
Total assets	$228.2M
Total cash	$180.5M
Total debt	$22.4M
Total liabilities	$61.8M
WACC	8.07%

Metric

Value

Altman Z-Score

-1.28

Book value per share

$1.96

Debt / equity

0.13

Interest coverage

-9,605.33

Long-term assets

$39.4M

Long-term liabilities

$19.8M

Net cash (debt)

$158.1M

Net cash / market cap

482.61%

Net cash growth

-31.86%

Net debt / equity

-0.95

Piotroski F-Score

Property, plant and equipment

$29.9M

Shareholders' equity

$166.4M

Tangible book value

$166.4M

Tangible book value per share

$1.96

Total assets

$228.2M

Total cash

$180.5M

Total debt

$22.4M

Total liabilities

$61.8M

WACC

8.07%

Metric	Value
Asset turnover	0.01
Current assets	$188.8M
Current liabilities	$41.9M
Current ratio	4.5
Inventory turnover	114.15
Net working capital	$-31M
Quick ratio	4.3
Working capital	$146.9M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$188.8M

Current liabilities

$41.9M

Current ratio

4.5

Inventory turnover

114.15

Net working capital

$-31M

Quick ratio

4.3

Working capital

$146.9M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-25.93%
Dividend yield	0%
Shareholder yield	-25.93%

Metric

Value

Buyback yield / dilution

-25.93%

Dividend yield

Shareholder yield

-25.93%

Metric	Value
10Y price change	-98.22%
10Y return CAGR	-33.16%
10Y total return	-98.22%
150-day SMA	$9.90
15Y price change	-99.07%
15Y return CAGR	-26.8%
15Y total return	-99.07%
1D price change	4.96%
1M price change	-89.47%
1M total return	-89.47%
1W price change	-5.9%
1W total return	-5.9%
1Y price change	-96.85%
1Y return CAGR	-96.86%
1Y total return	-96.85%
20-day SMA	$2.09
200-day SMA	$11.14
3M price change	-96.93%
3M total return	-96.93%
3Y price change	-93.54%
3Y return CAGR	-59.86%
3Y total return	-93.54%
50-day SMA	$3.43
50-day SMA vs 200-day SMA	50under200
52-week high	$19.11
52-week high date	2025-12-08
52-week low	$0.36
52-week low date	2026-10-27
5Y price change	-96.74%
5Y return CAGR	-49.58%
5Y total return	-96.74%
6M price change	-97.2%
6M total return	-97.2%
All-time high	$72.20
All-time high date	2010-12-22
All-time low	$0.36
All-time low date	2026-10-27
Average true range (ATR)	$0.30
Average volume	17.6M
Beta (1Y)	3.24
Beta (2Y)	2.33
Beta (5Y)	1.68
Change from 52-week high	-98.01%
Change from 52-week low	5.98%
Change from all-time high	-99.47%
Change from all-time low	6.01%
Change from open	5.83%
Day's gap	-0.83%
Dollar volume	$2.3M
High price	$0.39
Low price	$0.36
Monthly RSI	34.53
Open price	$0.36
Position in 52-week range	62.91%
Premarket change	-0.06%
Premarket close	$0.36
Premarket price	$0.36
Premarket volume	216.4K
Previous close	$0.36
Price vs 150-day SMA	-96.15%
Price vs 20-day SMA	-81.72%
Price vs 200-day SMA	-96.58%
Price vs 50-day SMA	-88.88%
Relative volume	0.35
RSI	15.87
Sharpe ratio	-1.32
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	0.09
Sortino ratio	-1.41
Sortino ratio (3Y)	0.16
Sortino ratio (5Y)	0.21
Volume	6.1M
Weekly RSI	24.21
YTD price change	-97.91%
YTD total return	-97.91%

Metric

Value

10Y price change

-98.22%

10Y return CAGR

-33.16%

10Y total return

-98.22%

150-day SMA

$9.90

15Y price change

-99.07%

15Y return CAGR

-26.8%

15Y total return

-99.07%

1D price change

4.96%

1M price change

-89.47%

1M total return

-89.47%

1W price change

-5.9%

1W total return

-5.9%

1Y price change

-96.85%

1Y return CAGR

-96.86%

1Y total return

-96.85%

20-day SMA

$2.09

200-day SMA

$11.14

3M price change

-96.93%

3M total return

-96.93%

3Y price change

-93.54%

3Y return CAGR

-59.86%

3Y total return

-93.54%

50-day SMA

$3.43

50-day SMA vs 200-day SMA

50under200

52-week high

$19.11

52-week high date

2025-12-08

52-week low

$0.36

52-week low date

2026-10-27

5Y price change

-96.74%

5Y return CAGR

-49.58%

5Y total return

-96.74%

6M price change

-97.2%

6M total return

-97.2%

All-time high

$72.20

All-time high date

2010-12-22

All-time low

$0.36

All-time low date

2026-10-27

Average true range (ATR)

$0.30

Average volume

17.6M

Beta (1Y)

3.24

Beta (2Y)

2.33

Beta (5Y)

1.68

Change from 52-week high

-98.01%

Change from 52-week low

5.98%

Change from all-time high

-99.47%

Change from all-time low

6.01%

Change from open

5.83%

Day's gap

-0.83%

Dollar volume

$2.3M

High price

$0.39

Low price

$0.36

Monthly RSI

34.53

Open price

$0.36

Position in 52-week range

62.91%

Premarket change

-0.06%

Premarket close

$0.36

Premarket price

$0.36

Premarket volume

216.4K

Previous close

$0.36

Price vs 150-day SMA

-96.15%

Price vs 20-day SMA

-81.72%

Price vs 200-day SMA

-96.58%

Price vs 50-day SMA

-88.88%

Relative volume

0.35

RSI

15.87

Sharpe ratio

-1.32

Sharpe ratio (3Y)

0.07

Sharpe ratio (5Y)

0.09

Sortino ratio

-1.41

Sortino ratio (3Y)

0.16

Sortino ratio (5Y)

0.21

Volume

6.1M

Weekly RSI

24.21

YTD price change

-97.91%

YTD total return

-97.91%

Metric	Value
Float	60.7M
Float percentage	70.38%
Shares change (QoQ)	0.63%
Shares change (YoY)	25.93%
Shares held by insiders	0.94%
Shares held by institutions	87.3%
Shares outstanding	86.2M
Short % of float	34.26%
Short % of shares	24.11%
Short ratio	5.9 days

Metric

Value

Float

60.7M

Float percentage

70.38%

Shares change (QoQ)

0.63%

Shares change (YoY)

25.93%

Shares held by insiders

0.94%

Shares held by institutions

87.3%

Shares outstanding

86.2M

Short % of float

34.26%

Short % of shares

24.11%

Short ratio

5.9 days

Metric	Value
Page views	138

Metric

Value

Page views

138

EyePoint, Inc. (EYPT)

Price

Financial snapshot

Fair-value bridge

Latest news · EYPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EYPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on EYPT

Frequently asked questions